标题
Treatment resistance in psychiatry: state of the art and new directions
作者
关键词
-
出版物
MOLECULAR PSYCHIATRY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-07-13
DOI
10.1038/s41380-021-01200-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Inflammatory Markers in Depression: a Meta-Analysis of Mean Differences and Variability in 5,166 Patients and 5,083 Controls
- (2020) Emanuele F. Osimo et al. BRAIN BEHAVIOR AND IMMUNITY
- Is the bell-shaped dose-response curve of the selective serotonin reuptake inhibitor due to 5-HT1A auto-receptors?
- (2020) Takeshi Terao et al. MEDICAL HYPOTHESES
- Impact of smoking behavior on clozapine blood levels – a systematic review and meta‐analysis
- (2020) E. Wagner et al. ACTA PSYCHIATRICA SCANDINAVICA
- Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications
- (2019) Toby Pillinger et al. PSYCHOPHARMACOLOGY
- Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression
- (2019) Roger S. McIntyre et al. JAMA Psychiatry
- Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
- (2019) Stephen J. Kaar et al. NEUROPHARMACOLOGY
- Esketamine for treatment resistant depression
- (2019) Sameer Jauhar et al. BMJ-British Medical Journal
- Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis
- (2019) Yuya Mizuno et al. NEUROPSYCHOPHARMACOLOGY
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Multiple-therapy-resistant major depressive disorder: a clinically important concept
- (2018) R. H. McAllister-Williams et al. BRITISH JOURNAL OF PSYCHIATRY
- Treatment-resistant depression and peripheral C-reactive protein
- (2018) Samuel R. Chamberlain et al. BRITISH JOURNAL OF PSYCHIATRY
- Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies
- (2018) Chiara Fabbri et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Treatment-resistant depression and suicidality
- (2018) Isidoor O. Bergfeld et al. JOURNAL OF AFFECTIVE DISORDERS
- Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
- (2018) Toby Pillinger et al. MOLECULAR PSYCHIATRY
- Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition
- (2018) Diego Hidalgo-Mazzei et al. BRITISH JOURNAL OF PSYCHIATRY
- Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies
- (2018) Tiago Reis Marques et al. PSYCHOLOGICAL MEDICINE
- A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis
- (2018) Toby Pillinger et al. SCHIZOPHRENIA BULLETIN
- Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines
- (2017) Michael Bauer et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
- (2017) M Kokkinou et al. MOLECULAR PSYCHIATRY
- Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
- (2017) A. Demjaha et al. PSYCHOLOGICAL MEDICINE
- Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia
- (2017) Theresa Wimberley et al. SCHIZOPHRENIA BULLETIN
- A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia
- (2017) Sameer Jauhar et al. JAMA Psychiatry
- Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization
- (2017) O D Howes et al. Translational Psychiatry
- Treatment-Resistant Depression in Primary Care across Canada
- (2017) Sakina J Rizvi et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
- (2016) Sidney H. Kennedy et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
- (2016) Roumen V. Milev et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
- (2016) Ronald S Duman et al. NATURE MEDICINE
- Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine
- (2016) Michael Soyka et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones
- (2016) Felice Iasevoli et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses
- (2016) J. Lally et al. PSYCHOLOGICAL MEDICINE
- Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder
- (2016) David Mataix-Cols et al. World Psychiatry
- Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia
- (2016) Myrto T. Samara et al. JAMA Psychiatry
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
- (2015) Gin S Malhi et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptoms
- (2015) Robert McCutcheon et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
- (2015) Anthony Cleare et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Assessment and Management of Treatment-Refractory Obsessive-Compulsive Disorder in Children
- (2015) Michael H. Bloch et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca’s area volume
- (2015) S G Fillman et al. MOLECULAR PSYCHIATRY
- Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
- (2015) Valeria Mondelli et al. SCHIZOPHRENIA BULLETIN
- The role of inflammation in schizophrenia
- (2015) Norbert Müller et al. Frontiers in Neuroscience
- A neurobiological hypothesis for the classification of schizophrenia: type a (hyperdopaminergic) and type B (normodopaminergic)
- (2014) Oliver D. Howes et al. BRITISH JOURNAL OF PSYCHIATRY
- A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
- (2014) David A. Mrazek et al. PSYCHIATRIC SERVICES
- Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method
- (2014) S. Leucht et al. SCHIZOPHRENIA BULLETIN
- Synaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine
- (2013) Ege T. Kavalali et al. AMERICAN JOURNAL OF PSYCHIATRY
- Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
- (2013) Arsime Demjaha et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function
- (2013) Arsime Demjaha et al. BIOLOGICAL PSYCHIATRY
- Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia
- (2013) Vidya Perera et al. Expert Opinion on Drug Metabolism & Toxicology
- New second-generation long-acting injectable antipsychotics for the treatment of schizophrenia
- (2013) Leslie Citrome Expert Review of Neurotherapeutics
- The social and economic burden of treatment-resistant schizophrenia
- (2013) James L. Kennedy et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders
- (2013) Michael E. Benros et al. JAMA Psychiatry
- Electroconvulsive Treatment: Hypotheses about Mechanisms of Action
- (2013) Roar Fosse et al. Frontiers in Psychiatry
- European Group for the Study of Resistant Depression (GSRD) — Where have we gone so far: Review of clinical and genetic findings
- (2012) Alexandra Schosser et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Assessment of posttraumatic stress disorder-related functional impairment: A review
- (2012) Paola Rodriguez et al. JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT
- Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas
- (2012) Rupert Lanzenberger et al. NEUROIMAGE
- Antipsychotics, dopamine D2 receptor occupancy and clinical improvement in schizophrenia: A meta-analysis
- (2012) Zeynep Yilmaz et al. SCHIZOPHRENIA RESEARCH
- A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
- (2012) Charles L. Raison et al. JAMA Psychiatry
- Unrecognised bipolar disorder in primary care patients with depression
- (2011) Daniel J. Smith et al. BRITISH JOURNAL OF PSYCHIATRY
- Plasma Olanzapine in Relation to Prescribed Dose and Other Factors
- (2011) Maxine X. Patel et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
- (2011) Thomas RE Barnes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Practice Parameter for the Assessment and Treatment of Children and Adolescents With Obsessive-Compulsive Disorder
- (2011) Daniel A. Geller et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Towards a glutamate hypothesis of depression
- (2011) Gerard Sanacora et al. NEUROPHARMACOLOGY
- Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood–brain barrier integrity
- (2011) Johann Steiner et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Is schizophrenia on the autism spectrum?
- (2010) Bryan H. King et al. BRAIN RESEARCH
- Sex differences in pharmacokinetics of antidepressants
- (2010) Nikolaos Kokras et al. Expert Opinion on Drug Metabolism & Toxicology
- Cytochrome P450 and ABCB1 genetics: association with quetiapine and norquetiapine plasma and cerebrospinal fluid concentrations and with clinical response in patients suffering from schizophrenia. A pilot study
- (2010) Georg Nikisch et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Path to Personalized Medicine
- (2010) Margaret A. Hamburg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Evidence and Potential Neurobiological Underpinnings of Unresolved Symptoms of Depression
- (2009) Madhukar H. Trivedi et al. JOURNAL OF CLINICAL PSYCHIATRY
- Reduced Neutrophil Count in People of African Descent Is Due To a Regulatory Variant in the Duffy Antigen Receptor for Chemokines Gene
- (2009) David Reich et al. PLoS Genetics
- Polymorphisms in the Drug Transporter Gene ABCB1 Predict Antidepressant Treatment Response in Depression
- (2008) Manfred Uhr et al. NEURON
- Estimates of Serotonin and Norepinephrine Transporter Inhibition in Depressed Patients Treated with Paroxetine or Venlafaxine
- (2008) Michael J Owens et al. NEUROPSYCHOPHARMACOLOGY
- From inflammation to sickness and depression: when the immune system subjugates the brain
- (2007) Robert Dantzer et al. NATURE REVIEWS NEUROSCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started